time
intens
durat
cytokin
cascad
reorgan
interrel
cytokin
network
fulli
understood
acut
infect
ahi
use
sequenti
plasma
sampl
collect
three
year
postinfect
cohort
msm
seroconvertor
determin
earli
kinet
cytokin
level
fiebigiiv
stage
use
luminexbas
multiplex
assay
cytokin
quantifi
relationship
cytokin
assess
spearman
correl
compar
hivneg
msm
hivinfect
individu
significantli
increas
multipl
plasma
cytokin
includ
gmcsf
vegf
acut
chronic
stage
infect
furthermor
rapid
diseas
progressor
rdp
earlier
robust
cytokin
storm
compar
slow
diseas
progressor
sdp
day
vs
day
respect
vs
chang
cytokin
respect
suggest
faster
stronger
cytokin
storm
ahi
could
promot
diseas
progress
hand
infect
induc
interlock
cytokin
network
establish
new
strong
correl
impos
higher
rigid
respect
statist
signific
correl
cytokin
rdp
sdp
p
studi
suggest
immunomodulatori
intervent
aim
control
cytokin
storm
ahi
may
benefici
slow
eventu
diseas
progress
immun
system
fight
pathogen
cytokin
activ
immun
cell
cell
macrophag
stimul
produc
cytokin
result
socal
cytokin
storm
cascad
grow
evid
immun
respons
initi
acut
hiv
infect
play
critic
role
modul
diseas
progress
sever
studi
investig
cascad
cytokin
product
peripheri
show
initi
rapid
product
follow
tumor
necrosi
factor
tnf
induc
protein
ip
interleukin
il
product
other
observ
chang
report
oppos
find
discrep
like
reflect
divers
uniti
dynam
ahi
also
could
due
part
variat
time
sampl
collect
among
studi
studi
crosssect
other
focus
time
point
rel
late
ahi
cytokin
storm
ahi
act
doubleedg
sword
potenti
caus
signific
damag
virusspecif
immun
also
inhibit
infect
reduc
cell
recruit
activ
studi
show
type
iifn
play
role
slow
diseas
progress
induc
multipl
antivir
gene
limit
initi
viral
replic
other
report
type
iifn
signal
link
immun
activ
viral
persist
block
type
iifn
lcmv
infect
enhanc
viral
clearanc
contradictori
report
suggest
need
investig
dynam
cytokin
natur
infect
infect
increas
cytokin
level
also
reorgan
cytokin
network
establish
new
strong
correl
variou
cytokin
thu
impos
high
rigid
cytokin
network
multipl
cytokin
storm
acut
phase
infect
order
investig
dynam
plasma
cytokin
hiv
infect
sequenti
longitudin
plasma
sampl
collect
preinfect
three
year
postinfect
analyz
shown
tabl
compar
hivneg
msm
control
hivinfect
individu
significantli
increas
plasma
cytokin
day
year
postinfect
increas
cytokin
includ
gmcsf
vegf
p
much
higher
level
observ
rdp
compar
sdp
interestingli
shown
fig
repres
cytokin
acut
stage
infect
plasma
cytokin
gmcsf
vegf
posit
chang
rdp
sdp
consid
dynam
chang
cytokin
might
relat
diseas
progress
analyz
plasma
level
cytokin
time
reach
peak
valu
found
cytokin
rapidli
increas
highest
level
wherea
other
took
much
longer
tabl
exampl
plasma
rdp
reach
peak
valu
day
post
infect
wherea
gmcsf
vegf
delay
day
post
infect
rdp
interestingli
rdp
much
earlier
stronger
cytokin
storm
acut
stage
compar
sdp
day
vs
day
respect
vs
chang
respect
exampl
increas
seen
rdp
day
infect
increas
sdp
day
infect
cytokin
rdp
approxim
time
initi
elev
peak
valu
day
postinfect
wherea
cytokin
sdp
addit
hierarchi
cytokin
induct
differ
sdp
rdp
group
rdp
significantli
earli
increas
delay
vegf
compar
sdp
surprisingli
sdp
reach
peak
valu
day
infect
compar
day
rdp
consid
cytokin
storm
trigger
hiv
analyz
dynam
viru
replic
kinet
relationship
cytokin
storm
surpris
shown
fig
found
drop
viral
load
peak
setpoint
follow
declin
cytokin
rdp
wherea
cytokin
increas
sdp
second
wave
plasma
cytokin
storm
chronic
stage
hiv
infect
next
ask
whether
hiv
infect
individu
higher
sustain
level
plasma
cytokin
chronic
infect
compar
hivneg
control
shown
tabl
compar
hivneg
msm
chronic
rdp
group
n
sdp
group
n
p
valu
hivinfect
individu
significantli
increas
plasma
gmcsf
vegf
much
higher
level
observ
rdp
compar
sdp
p
ask
whether
rdp
higher
level
plasma
cytokin
sdp
chronic
infect
acut
diseas
shown
fig
rdp
sdp
high
level
plasma
cytokin
viral
set
point
second
wave
cytokin
storm
chronic
stage
gmcsf
vegf
increas
cytokin
increas
fold
cytokin
less
chang
interest
signific
differ
level
time
reach
peak
valu
second
wave
two
group
data
shown
correl
among
plasma
cytokin
concentr
infect
hiv
diseas
progress
result
signific
modif
interconnect
cytokin
belong
function
distinct
class
median
correl
coeffici
vs
significantli
differ
sdp
rdp
p
significantli
differ
plasma
hivuninfect
healthi
subject
p
fig
furthermor
rdp
statist
signific
correl
level
individu
cytokin
contrast
sdp
correl
p
thu
cytokin
network
becom
interlock
sdp
rdp
new
correl
establish
correl
lost
preexist
correl
increas
magnitud
decreas
exampl
correl
found
rdp
new
statist
signific
correl
includ
establish
cytokin
sdp
anoth
exampl
rel
weak
correl
rdp
r
p
becam
strong
one
sdp
r
p
studi
previous
shown
cytokin
cascad
found
ahi
might
contribut
control
viral
replic
howev
extent
durat
exponenti
cytokin
expans
acut
infect
poorli
understood
studi
abl
investig
earli
event
first
sever
week
post
infect
sinc
exact
infect
date
hard
know
plasma
sampl
acut
infect
difficult
collect
studi
report
dynam
profil
cytokin
preinfect
acut
chronic
stage
infect
first
find
studi
rdp
rapidli
increas
cytokin
peripher
blood
earli
infect
wherea
sdp
delay
mild
increas
plasma
cytokin
data
overwhelm
suggest
increas
cytokin
earli
infect
relat
immunopathogenesi
rapid
diseas
progress
consist
report
find
hbv
hcv
sar
sever
acut
respiratori
syndrom
infect
second
found
rdp
dispar
cytokin
profil
compar
sdp
multipl
cytokin
rdp
includ
gcsf
reach
peak
valu
week
infect
wherea
spd
lack
sdp
consist
result
anoth
report
also
shown
elev
acut
hiv
infect
secret
nk
cell
cell
cytotox
lymphocyt
activ
infect
broad
effect
immun
activ
proinflammatori
respons
immun
modul
interest
found
sdp
reach
peak
valu
much
earlier
time
rdp
vitro
studi
shown
decreas
secret
modul
monocyt
toward
support
agspecif
cell
medic
respons
data
suggest
rapid
increas
sdp
might
play
role
augment
agspecif
cell
medic
respons
relat
slow
diseas
progress
consist
report
cytokin
storm
ahi
found
order
sequenc
increas
cytokin
acut
stage
rdp
first
rapid
transient
elev
gcsf
week
detect
peak
viral
load
declin
parallel
decreas
viral
replic
suggest
viru
directli
indirectli
drive
product
cytokin
rapid
moresustain
elev
level
follow
gmcsf
month
postinfect
accompani
recoveri
cell
late
increas
cytokin
vegf
around
month
infect
complex
chang
dynam
cytokin
rdp
happen
sdp
much
delay
milder
chang
plasma
cytokin
data
suggest
vigor
cytokin
storm
rdp
earli
infect
reflect
battl
viru
replic
host
immun
respons
result
immunopathogenesi
rapid
diseas
progress
wide
accept
cytokin
form
coordin
complex
network
studi
allow
us
reveal
interact
differ
cytokin
product
immunosuppress
cytokin
like
becam
strong
correl
slow
progress
group
compar
rapid
progress
group
consist
report
dr
andrea
lisco
group
other
demonstr
cours
hiv
infect
variou
cytokin
upor
downregul
blood
semen
interlock
uninfect
individu
precis
character
rigid
network
slow
rapid
progressor
found
cytokin
relat
sdp
rdp
reveal
infect
impos
qualit
new
order
cytokin
network
underli
cellular
network
may
contribut
immunodefici
although
multipl
function
mani
cytokin
complet
understood
know
exact
function
mean
correl
whether
direct
effect
immun
respons
studi
show
mani
posit
correl
built
blood
individu
larger
cohort
studi
may
reveal
critic
factor
associ
regul
cytokin
network
indic
novel
target
therapi
strategi
limit
studi
includ
small
number
patient
introduc
possibl
bia
could
lead
underestim
true
differ
addit
individu
syphili
rdp
sdp
may
contribut
immun
activ
lead
transient
increas
rna
plasma
level
decreas
cell
count
howev
shown
syphili
appar
longterm
impact
progress
summari
knowledg
studi
first
investig
cytokin
cascad
associ
network
among
msm
seroconvert
studi
construct
comprehens
pictur
dynam
cytokin
earliest
stage
infect
analyz
sequenti
plasma
sampl
acut
hivinfect
msm
studi
reveal
impress
broad
cytokin
storm
ahi
patient
rapid
diseas
progress
suggest
rational
control
cytokin
storm
earli
infect
first
month
may
benefici
immun
recoveri
slow
diseas
progress
hospit
research
ethic
committe
studi
particip
provid
written
inform
consent
upon
admiss
inform
store
use
research
method
carri
accord
approv
guidelin
regul
studi
popul
design
consent
msm
newli
infect
recruit
beij
primo
cohort
prospect
cohort
hivneg
msm
screen
hiv
everi
week
estim
time
infect
defin
midpoint
last
hiv
antibodi
neg
test
first
hiv
antibodi
posit
test
day
prior
posit
rna
pcr
assay
day
neg
hiv
enzym
immunoassay
acut
case
detect
week
post
infect
select
rapid
progressor
whose
cell
decreas
l
within
year
slow
progressor
retain
cell
cell
luminex
cytokin
concentr
plasma
determin
use
highsensit
human
cytokin
milliplex
map
kit
millipor
interleukin
il
receptor
agonist
ra
epiderm
growth
factor
egf
eotaxin
granulocyt
coloni
stimul
factor
gcsf
granulocytemacrophag
gm
csf
interferon
ifn
ifngammainduc
protein
ip
monocyt
chemotact
protein
mcp
macrophag
inflammatori
protein
mip
vascular
endotheli
growth
factor
vegf
sampl
assay
duplic
cytokin
standard
suppli
manufactur
run
plate
data
acquir
use
system
analyz
use
bioplex
manag
softwar
biorad
cytokin
concentr
lower
limit
detect
report
midpoint
lowest
concentr
cytokin
measur
zero
statist
analysi
nonparametr
mannwhitney
u
test
use
compar
median
plasma
cytokin
concentr
two
diseas
progress
group
pvalu
consid
statist
signific
correl
among
plasma
cytokin
concentr
healthi
subject
individu
determin
use
spearman
correl
coeffici
correl
matric
display
schemat
correlogram
due
wide
rang
cytokin
measur
fold
chang
cytokin
level
refer
level
determin
median
cytokin
hivneg
msm
use
follow
dynam
analysi
dynam
plasma
cytokin
fit
chang
fold
along
time
line
local
weight
scatterplot
smooth
lowess
bandwidth
import
paramet
determin
trial
error
point
first
second
peak
smooth
fit
curv
determin
visual
xaxi
yaxi
coordin
point
regard
durat
magnitud
cytokin
elev
peak
respect
statist
analys
conduct
statas
open
sourc
procedur
r
